Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma

American Journal of Hematology · Published 2026-06-15 · DOI 10.1002/ajh.70414

Free full text

Authors (25)

Jessica McElwee, Grace Elsey, Rebecca Gonzalez, Kelley Julian, Jordan Snyder, Katelynn Granger, Mikhaila Rice, Victoria R. Nachar, Shebli Atrash, Doris K. Hansen, Ariel Grajales‐Cruz, Christopher Cahoon, Baylee Bryan, Douglas Sborov, Zahra Mahmoudjafari, Matthew Warrick, Anthony Dominick, Joslyn Rudoni, Jonathan Kissam, Megan Vince, Jack Khouri, Iman Ahmed, Matthew Pianko, Donald C. Moore, James A. Davis

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

McElwee, J., Elsey, G., Gonzalez, R., et al. (2026). Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma. American Journal of Hematology. https://doi.org/10.1002/ajh.70414

Related articles